Microsomal triglyceride transfer protein (MTP) is required for the assembly and secretion of apolipoprotein (apo) B-containing lipoproteins. Previously, we demonstrated that the N-terminal 1000 residues of apoB (apoB:1000) are necessary for the initiation of apoB-containing lipoprotein assembly in rat hepatoma McA-RH7777 cells and that these particles are phospholipid (PL)-rich. To determine if the PL transfer activity of MTP is sufficient for the assembly and secretion of primordial apoB:1000-containing lipoproteins, we employed microRNA-based short hairpin RNAs (miR-shRNAs) to silence Mttp gene expression in parental and apoB:1000-expressing McA-RH7777 cells. This approach led to 98% reduction in MTP protein levels in both cell types. Metabolic labeling studies demonstrated a drastic 90-95% decrease in the secretion of rat endogenous apoB100-containing lipoproteins in MTP-deficient
INTRODUCTION
Apolipoprotein (apo) 2 B has a fundamental role in the transport and metabolism of plasma triacylglycerols (TAG) and cholesterol, and is synthesized primarily in hepatocytes and enterocytes (1, 2, 3 ) . ApoB is present as a single molecule per lipoprotein particle (4) and exists in two forms, apoB100
(the full-length protein) and apoB48 (the N-terminal 48% of apoB100). The two forms derive from the same gene by a post-transcriptional modification of the apoB mRNA at codon 2153 that converts a glutamine codon to a stop codon (5) . Studies by Xie et al. (6) provided the first biologically plausible role for mammalian intestinal apoB mRNA editing mechanism. ApoB100 is an essential structural component for the formation and secretion of very low density lipoproteins (VLDL) and is essentially the only apoprotein component of low density lipoproteins (LDL) (3, 7, 8) . ApoB48 is required for the formation and secretion of chylomicrons, and is expressed in mammalian intestine and in the liver of some non-human mammals (3, 9) .
The processes involved in the assembly of apoB-containing lipoproteins in the liver are complex and are regulated at multiple levels throughout the secretory pathway. The addition of lipids to apoB is widely believed to occur in two steps (3, 10, 11) . The first step involves the addition of small amounts of lipids to apoB as it is translated and translocated into the lumen of endoplasmic reticulum (ER), preventing its degradation and allows for the formation of a partially lipidated small pre-VLDL particle in the high density lipoprotein (HDL) density range (3, 11, 12) . In the second step, this pre-VLDL particle acquires the bulk of its core lipids and is converted to bona fide VLDL (3, 11, 13) , presumably by fusing with a large, VLDL-sized, apoB-free TAG particle (13, 14) . Microsomal triglyceride transfer protein (MTP) plays a pivotal role in the assembly and secretion of apoB-containing lipoproteins (15) (16) (17) (18) . MTP is widely believed to play a critical role in the first-step assembly of apoB (19-24), but it is not required for the second-step core expansion during VLDL assembly (20, 22, 24, 25) . On the other hand, several studies support the concept that MTP is essential for bulk TAG transfer and subsequent conversion of small apoB100-containing lipoproteins to large VLDL-sized particles (26-29) and chylomicrons (30).
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particle assembly or the second-step particle core expansion. Rather, the objective here was to assess the role of MTP in the initial addition of phospholipids to the N-terminal 1000 residues of apoB100 and nucleation of the primordial pre-nascent apoB-containing initiation complex. We consider this early stage in apoB particle assembly to be distinct from the first-step assembly of HDL-sized apoB lipoproteins.
Previous experimentally-derived results in lipoprotein-producing rat hepatoma McA-RH7777 cells (31) and molecular modeling of the βα 1 domain (residues 1-1000) of apoB100 (32) indicated that the Nterminal 1000 residues of apoB (referred to as apoB:1000, corresponding to apoB22.05) are required for the initiation of apoB particle assembly without a structural requirement for MTP. These results supported the earlier proposal by Segrest et al. (33, 34) . This primordial apoB:1000-containing lipoprotein particle was shown to be phospholipid (PL)-rich with a fixed lipid capacity on the order of 50
PL for a total stoichiometry of 70 lipid molecules per particle (31) . Subsequent studies (35) were carried out to determine if MTP lipid transfer activity is required for the formation of the PL-rich primordial apoB:1000-containing lipoprotein particle. Results demonstrated that MTP inhibitors, BMS-200150 and BMS-197636 (36, 37) , and siRNA-mediated suppression of Mttp gene expression by 60% in apoB:1000-expressing McA-RH7777 cells had no detectable effect on the synthesis, lipidation and secretion of apoB:1000-containing particles (35) . However, it has been argued that it is possible that the remaining 40% of MTP activity is sufficient to mediate the initiation of apoB lipoprotein assembly (38) . This valid point is based on the results of a study demonstrating that the phospholipid transfer activity of MTP is sufficient for the assembly and secretion of primordial apoB lipoproteins in transformed African green monkey kidney fibroblast COS cells (39) . To determine if this mechanism is active in hepatocytes, and as a logical and necessary continuation of our studies, we used micro (mi) RNA-based short hairpin RNAs (miR-shRNAs) and silenced the Mttp gene expression in parental and apoB:1000-expressing McA-RH7777 cells by 98%. Results of metabolic labeling studies strongly indicate that phospholipid transfer activity of MTP is not required for the assembly and secretion of primordial pre-nascent apoB:1000-containing particles in hepatocytes. This study indicates that, in hepatocytes, factor(s) other than MTP are involved in the formation of PL-rich apoB:1000-containing initiation complex. Plasmids were purified using standard techniques, analyzed to confirm correct sequence, and used to transfect parental and apoB:1000-expressing McA-RH7777 cells as previously described (31, 35, 40, 44) . and apoB48 in the conditioned medium were isolated by immunoprecipitation using monospecific polyclonal antibody to rat apoB (developed in our laboratory) as described (35) . conditioned medium was subjected to 4-20% NDGGE as previously described (31, 40) . Gels were stained and the bands corresponding to rat endogenous apoB100 or human apoB:1000, identified by immunoblotting of a duplicate gel, were excised and analyzed for lipids as described below.
MATERIALS AND METHODS

Materials
Lipid Analysis of Isolated Full-Length and Truncated ApoB-Containing Particles
lipids associated with the gel-isolated rat endogenous apoB100-or human apoB:1000-containing particles were extracted with chloroform/methanol (2:1) as previously described in detail (31) . The extracted lipids were applied to thin layer chromatography (TLC) plate and bands corresponding to PL, diacylglycerols (DAG), and TAG, identified by comparison to known standards, were scraped off the plate and quantified by liquid scintillation (31) .
Immunoblot Analysis -The human apoB:1000-containing particles were separated by 4-12% SDS-PAGE (48) or 4-20% NDGGE. After electrophoresis, proteins were detected by Western blot analysis (46) using biotinylated antibody to human apoB100 as previously described (40) . The level of MTP protein in the cells was determined by Western blot analysis using polyclonal antibody to bovine MTP 97-kDa large subunit (15) . Although McA-RH cells are known to secrete predominantly apoB100-containing lipoproteins (51-53), they also secrete apoB48. Therefore, the role of MTP in the secretion of apoB48 was examined by (Fig. 2 C) .
Microsomal Triglyceride Transfer Protein Activity Assay
RESULTS
RNAi-mediated Silencing of Mttp Gene Expression in
Furthermore, addition of BMS-197636 (0.1 µM) abolished the secretion of both apoB100 and apoB48
( Fig. 2 C) . These results suggest that, under the experimental conditions employed, MTP is required for the secretion of both apoB100 and apoB48 in McA-RH cells.
RNAi-mediated Silencing of MTP Gene Expression in Parental McA-RH Cells Markedly Reduces the Lipid Content and Alters the Lipid Composition of Rat Endogenous ApoB100-containing Particles -
The effect of MTP silencing on the lipidation of rat endogenous apoB100-containing particles is shown in McA-RH cells (data not shown). This decrease was more pronounced in TAG than in PL and DAG resulting in the secretion of LDL-sized apoB100-containing particles that contained a lower percent content of TAG and higher percent contents of PL (data not shown). (Figures 1 and 2 ).
Effect of MTP Deficiency on the Synthesis and Secretion of Human
As shown in Figure 3 A (representative of three individual dishes), we found equivalent levels of MTP mRNA in parental untransfected McA-RH cells (Fig. 3 A, lane 1), control apoB:1000-expressing
McA-RH cells (Fig. 3 A, lane 2), and apoB:1000-expressing McA-RH cells transfected with miRshRNA-negative control ( Fig. 3 A, lane 3) . Transfection of apoB:1000-expressing McA-RH cells with miR-shRNA-MTP (Fig. 3 A, lane 4) decreased the levels of MTP mRNA by 90% compared with negative control apoB:1000-expressing McA-RH cells (Fig. 3 A, lane 3) . The GAPDH mRNA level was the same in all four cell lines supporting the specificity of miR-shRNA-MTP (Fig. 3 A) . The apoB mRNA levels were the same in all four cell lines (Fig. 3 A) indicating that MTP deficiency does not alter
ApoB gene expression in McA-RH cells. The MTP mRNA levels were also determined by real-time PCR (Fig. 3 B) and confirmed the results obtained by semi-quantitative RT-PCR (Fig. 3 A) . The MTP mRNA levels in MTP-deficient parental and apoB:1000-expressing McA-RH cells were decreased by approximately 98% when compared with control parental untransfected McA-RH cells (Fig. 3 B) .
Western blot analysis, using polyclonal antibody to bovine MTP 97-kDa large subunit (15) further effect on the net synthesis and secretion of apoB:1000 (Fig. 4 C) . Thus, total elimination of MTP activity did not significantly affect the total synthesis and secretion of apoB:1000 (Fig. 4 D) . NDGGE. Gels were run in duplicates; one gel was analyzed by Western blotting using polyclonal antibody to human apoB100 ( Figure 5 A) and the second gel was stained and subjected to autoradiography (Fig. 5 B) . Western blot analysis demonstrated equal levels of apoB:1000 in intact particles secreted by control apoB:1000-expressing McA-RH cells (Fig. 5 A, lanes 1 and 2) and cells transfected with either miR-shRNA-negative control (Fig. 5 A, lanes 3 and 4) or miR-shRNA-MTP ( associated with the apoB:1000-containing bands and normalized for cell protein, showed that the absence of MTP had no effect on the lipid content of the secreted apoB:1000-containing particles (Fig. 5 C) .
MTP Deficiency Has no Detectable Effect on the Content or Composition of Lipids Associated With
In a separate series of four experiments, the [ 3 H]-labeled apoB:1000-containing particles were excised from the native gels and lipids were extracted from the particles as previously described (31) . 
Discussion
Despite myriad studies on the role of MTP in VLDL secretion, its requirement for the initial step of apoB particle assembly remains controversial. The mechanisms involved in the assembly and secretion of apoB-containing lipoproteins have been under intense investigation in our laboratory. Specifically, we have focused on structural elements in apoB that are required for the initiation of particle assembly.
Based on our experimentally-derived results (31) and molecular modeling of the βα 1 domain (residues 1-1000) of apoB100, referred to as apoB:1000 (32), we previously proposed a model for the initiation of apoB particle assembly. In this model, the first 1000 residues of apoB are required for the formation of a stable initiation complex that is phospholipid-rich and has a maximum capacity on the order of 50 molecules of phospholipids (31) . We proposed that this primordial apoB particle can be formed without a structural requirement for MTP via four salt bridges between a tandem series of four charged residues (Arg997, Glu998, Asp999 and Arg1000) located at the C-terminal end of the model, with a complementary tandem series of four charges (Glu720, His719, Lys718, Asp717) in the unmodeled loop region (residues 670-745) (32) . In a recent publication (44), our site-directed mutation studies provided experimentally-derived evidence in support of this model. (35) . Results demonstrated that inhibition of MTP activity had no effect on the synthesis, lipidation and secretion of apoB:1000-containing particles in stable transformants of McA-RH cells (35) . Considering the possibility that these inhibitors may not be totally specific, we were compelled to examine the secretion of apoB:1000 in siRNA-mediated MTP-knockdown McA-RH cells.
Results showed that 60% reduction in Mttp gene expression had no detectable effect on the assembly and secretion of apoB:1000-containing particles (35) . However, it has been argued that the remaining 40% of MTP might be sufficient to mediate the initiation of apoB particle assembly (38) . One of the most convincing mean of precluding this possibility was to achieve complete silencing of Mttp gene expression The marked reduction in the synthesis, lipidation and secretion of rat endogenous apoB100 in MTPdeficient McA-RH cells corresponded to the decrease in MTP mRNA and protein levels in these cells.
MTP deficiency also diminished the secretion of a 250 kDa protein to the same extent as that of apoB100.
Since this protein was immunoprecipitated by a monospecific polyclonal antibody to rat apoB, it is presumed to be rat endogenous apoB48. Thus, under the experimental conditions employed in this study, we conclude that MTP is required for the secretion of both apoB100 and apoB48 in rat hepatoma McA-RH cells. While studies in mice with liver-specific inactivation of Mttp gene have consistently demonstrated a marked reduction ( > 95%) in the plasma levels and hepatic secretion of apoB100 (28, 29, 55), results on apoB48 are more variable. Using liver-specific Mttp knockout mice, one study found a marked reduction in plasma apoB48 (54) while another study found moderate decreases in both the plasma level and hepatic secretion of apoB48 (28). Yet, a third study observed variable changes in plasma apoB48 ranging from no change to ~50% reduction and a modest decrease in hepatic secretion of apoB48 (28). The variability in the plasma levels of apoB48 in the above studies could be explained by potential differences in the intestinal secretion of apoB48 in liver-specific Mttp knockout mice under different dietary conditions. However, the observed reduction in hepatic apoB48 would imply that the secretion of both apoB100 and apoB48 from hepatocytes requires the presence of functional MTP. MTP is believed to facilitate the stabilization of newly synthesized apoB48 (20) and apoB100 (23) shortly after completion of translation but before the addition of any major amount of lipids to the particle. In the absence of MTP, majority of apoB100 and apoB48 undergo intracellular degradation and only small amounts are secreted (56, 57) . Our results on the role of MTP in the secretion of apoB100 and apoB48 in
McA-RH cells are not in conflict with the above published studies.
In striking contrast to the marked reduction in the secretion of rat endogenous apoB100 and apoB48, the near absence of MTP had no significant effect on the synthesis and secretion of apoB:1000 in stable transformants of McA-RH cells. Likewise, identical levels of labeled lipids were found associated with apoB:1000-containing particles secreted by cells that did not express any detectable MTP and cells that expressed the full complement of functional MTP. Importantly, the lipid composition of the secreted apoB:1000-containing particles was the same regardless of the presence or absence of MTP expression.
These results do not support the notion that phospholipid transfer activity of MTP is sufficient to initiate apoB particle assembly in hepatocytes, a process that is apparently active in nonhepatic COS cells (39) .
The detection of trace amount of MTP protein (2%) and activity (~8%) in MTP-deficient apoB:1000- An inevitable question is how our results can be reconciled with the well-established role of MTP in the assembly and secretion of apoB-containing lipoproteins (16, 17) . A prudent answer is that our data by guest, on October 22, 2017
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neither dispute the role of MTP in the first-step assembly of small, HDL-sized apoB100-or apoB48-containing nascent particles nor are sufficient in scope to allow any speculation of the role of MTP in the second-step particle core expansion. The present study was designed to resolve the fundamental question of requirement of MTP in the earliest stage of apoB particle assembly. Results strongly support our concept that the initial addition of fixed numbers of PL molecules to the apoB -lipid pocket‖ (31) and nucleation of apoB:1000-containing initiation complex occurs independently of MTP. There are ample published studies that support our conclusion. In McA-RH cells, the secretion of human apoB29 and apoB18 was not affected by MTP inhibitors (59) . In HepG2 cells, synthesis of apoB polypeptides the size of 100-200 kDa was insensitive to MTP inhibitors, suggesting that functional MTP was not required for the initiation of apoB100 translation (21). Murine mammary-derived cells, which lack MTP, secrete human apoB41on small HDL-sized particles (60) . Sequences in the C terminus of apoB29 bind PL and are secreted by cells lacking MTP (61) whereas segments equal to or greater than apoB48 containing the N-terminal 17% of the protein respond to MTP activity (62) . Our results are in accord with the above published studies.
In conclusion, we have produced a viable MTP-deficient parental and apoB:1000-expressing McA-RH cells using miR-shRNAs. We found that the near absence of MTP in parental McA-RH cells abolished the secretion of rat endogenous apoB100 and apoB48 and diminished the secretion of lipidated apoB100-containing particles. In striking contrast, MTP deficiency had no significant effect on the synthesis, lipidation and secretion of human apoB:1000-containing particles. These results provide highly compelling evidence in support of our concept that, in hepatocytes, early acquisition of phospholipids by apoB:1000 leading to the assembly of the primordial apoB:1000-containing initiation complex occurs independently of MTP. This study underscores the need for considering targets other than MTP when designing strategies aimed at preventing hepatic overproduction of apoB-containing Control stable transformants of apoB:1000-expressing McA-RH cells and cells that were transfected with either miR-shRNA-negative control or miR-shRNA-MTP targeted to 3' UTR of MTP were incubated with serum-free DMEM containing [ 3 H]-labeled glycerol (7 µCi/ml of medium) for 17-20 h. Secreted apoB1000-containing particles were isolated by NDGGE and analyzed for lipids as described in Experimental Procedures.
Values are mean ± SE of nine samples from four separate experiments. 
